One-year outcomes of a digital twin intervention for type 2 diabetes: a retrospective real-world study
Open Access
- 26 October 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-11
Abstract
This retrospective observational study, building on prior research that demonstrated the efficacy of the Digital Twin (DT) Precision Treatment Program over shorter follow-up periods, aimed to examine glycemic control and reduced anti-diabetic medication use after one-year in a DT commercial program. T2D patients enrolled had adequate hepatic and renal function and no recent cardiovascular events. DT intervention powered by artificial intelligence utilizes precision nutrition, activity, sleep, and deep breathing exercises. Outcome measures included HbA1c change, medication reduction, anthropometrics, insulin markers, and continuous glucose monitoring (CGM) metrics. Of 1985 enrollees, 132 (6.6%) were lost to follow-up, leaving 1853 participants who completed one-year. At one-year, participants exhibited significant reductions in HbA1c [mean change: -1.8% (SD 1.7%), p < 0.001], with 1650 (89.0%) achieving HbA1c below 7%. At baseline, participants were on mean 1.9 (SD 1.4) anti-diabetic medications, which decreased to 0.5 (SD 0.7) at one-year [change: -1.5 (SD 1.3), p < 0.001]. Significant reductions in weight [mean change: -4.8 kg (SD 6.0 kg), p < 0.001], insulin resistance [HOMA2-IR: -0.1 (SD 1.2), p < 0.001], and improvements in β-cell function [HOMA2-B: +21.6 (SD 47.7), p < 0.001] were observed, along with better CGM metrics. These findings suggest that DT intervention could play a vital role in the future of T2D care.Keywords
All Related Versions
Funding Information
- Twin Health Inc.
This publication has 32 references indexed in Scilit:
- Digital Twin-Enabled Personalized Nutrition Improves Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes: Results of a 1-Year Randomized Controlled StudyEndocrine Practice, 2023
- Impact of a Low-Carbohydrate Compared with Low-Fat Breakfast on Blood Glucose Control in Type 2 Diabetes: A Randomized TrialThe American Journal of Clinical Nutrition, 2023
- A scalable, virtual weight management program tailored for adults with type 2 diabetes: effects on glycemic controlNutrition & Diabetes, 2023
- Toward an Optimal Definition of Hypoglycemia with Continuous Glucose MonitoringComputer Methods and Programs in Biomedicine, 2021
- Time-in-range as a target in type 2 diabetes: An urgent needHeliyon, 2021
- Human postprandial responses to food and potential for precision nutritionNature Medicine, 2020
- Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled StudyDiabetes Therapy, 2018
- Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trialThe Lancet, 2018
- Major rapid weight loss induces changes in cardiac repolarizationJournal of Electrocardiology, 2016
- Personalized Nutrition by Prediction of Glycemic ResponsesCell, 2015